InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Lis William, Director. Director active across 3 companies, notably Zai Lab Ltd. Cumulatively, 15 disclosures have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €1.2m. History available since 3 January 2022. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lis William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
8,506 shares@ US$25.000.0080% mcap9.9% of flowAmerican Depositary SharesSEC:0000905148-26-003620:0
10,831 shares0American Depositary SharesSEC:0000905148-25-002215:0
15,000 shares@ US$32.9832.2% of flowAmerican Depositary SharesSEC:0000905148-25-000827:0
10,297 shares@ US$17.313911.2% of flowAmerican Depositary SharesSEC:0000905148-24-001839:0
21,253 shares0American Depositary SharesSEC:0000905148-24-001748:0
7,965 shares@ US$0.85089.9% of flowVoting Common StockSEC:0001013762-23-003901:0
18,903 shares@ US$26.4531.1% of flowAmerican Depositary SharesSEC:0000950170-23-031097:0
8,500 shares@ US$1.4417.0% of flowVoting Common StockSEC:0001213900-23-029888:0
5,434 shares@ US$38.3113.3% of flowAmerican Depositary SharesSEC:0000899243-23-007333:0
29,500 shares0Voting Common StockSEC:0001213900-22-063936:0
24,743 shares@ US$2.0220.22% mcap100.0% of flowVoting Common StockSEC:0001213900-22-035570:0
89,972 shares0Voting Common StockSEC:0001213900-22-014562:0
1,926 shares@ US$53.406.0% of flowOrdinary SharesSEC:0001567619-22-001445:0
7,763 shares0Ordinary SharesSEC:0001567619-22-000397:0
28,125 sharesCommon StockSEC:0001209191-16-094215:0
15 of 15 declarations
About Lis William
Lis William is an Administrateur at Zai Lab Ltd and Jasper Therapeutics, Inc., and Chief Executive Officer at PORTOLA PHARMACEUTICALS INC. He has 14 filings in total, and across the 14 sampled filings between 2016-01-29 and 2025-06-23, sell transactions total 994065 EUR and Attribution is the modal transaction nature.
